Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?
- PMID: 23700214
- DOI: 10.1245/s10434-013-2990-x
Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?
Abstract
Background: This study was designed to evaluate the feasibility and the role of thyroid ultrasound (US) in predicting malignancy for Bethesda system III nodules and to suggest management guidelines for these nodules.
Methods: A total of 155 thyroid nodules with Bethesda system III cytology in 155 patients with surgery or follow-up repeat FNA were included in this study. On the basis of US features, final assessment for thyroid nodules were prospectively classified into one of three categories: (1) probably benign, (2) low suspicious for malignancy, and (3) suspicious for malignancy. The clinicopathologic characteristics of patients and US features of nodules were compared according to malignancy and benignity.
Results: Of the 155 Bethesda system III nodules, 69 (44.5%) underwent surgery without repeat FNA and 86 (55.5%) nodules underwent repeat FNA, and a malignancy rate of 55.5% (86/155) was determined. Thyroid nodules with concurrent thyroid cancer were more likely to be malignant (P<0.001). The malignancy rate of sonographically suspicious for malignancy was 100%, higher than the 58% of sonographically low suspicious for malignancy, and 7.7% of sonographically probably benign nodules (P<0.001).
Conclusions: US assessment may help the clinician decide between surgery and repeat FNA for managing Bethesda system III nodules. When the US assessment for the thyroid nodules is suspicious for malignancy, repeat FNA may be unnecessary and surgery should be considered.
Similar articles
-
Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?PLoS One. 2015 Jun 26;10(6):e0130138. doi: 10.1371/journal.pone.0130138. eCollection 2015. PLoS One. 2015. PMID: 26115096 Free PMC article.
-
Predictive factors of malignancy in thyroid nodules with repeatedly nondiagnostic cytology (Bethesda category I): value of ultrasonography.Horm Metab Res. 2014 Apr;46(4):294-8. doi: 10.1055/s-0034-1367044. Epub 2014 Feb 6. Horm Metab Res. 2014. PMID: 24505030
-
Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.Thyroid. 2014 Jul;24(7):1115-20. doi: 10.1089/thy.2013.0650. Epub 2014 May 9. Thyroid. 2014. PMID: 24684285
-
Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.Medicine (Baltimore). 2017 Apr;96(16):e6564. doi: 10.1097/MD.0000000000006564. Medicine (Baltimore). 2017. PMID: 28422844 Free PMC article. Review.
-
Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18. Cytopathology. 2013. PMID: 23078633 Review.
Cited by
-
Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?PLoS One. 2015 Jun 26;10(6):e0130138. doi: 10.1371/journal.pone.0130138. eCollection 2015. PLoS One. 2015. PMID: 26115096 Free PMC article.
-
The Correlation of Age with Prognosis of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodules.Cancer Manag Res. 2021 Apr 8;13:3101-3111. doi: 10.2147/CMAR.S304686. eCollection 2021. Cancer Manag Res. 2021. PMID: 33854379 Free PMC article.
-
Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS.Cancers (Basel). 2022 Sep 16;14(18):4489. doi: 10.3390/cancers14184489. Cancers (Basel). 2022. PMID: 36139649 Free PMC article.
-
BRAF V600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules.Cancer Biol Med. 2019 Feb;16(1):131-138. doi: 10.20892/j.issn.2095-3941.2018.0291. Cancer Biol Med. 2019. PMID: 31119053 Free PMC article.
-
Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.Endocrine. 2016 Oct;54(1):156-168. doi: 10.1007/s12020-016-0982-x. Epub 2016 May 12. Endocrine. 2016. PMID: 27172917
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources